ERBB2 and prostate carcinoma: ACP3 is a prostatic acid phosphatase that also regulates prostate cancer cell growth by dephosphorylating ERBB2, which is a part of the adjacent network of our target gene CHST2 in our previous study [99] that shows a slight negative correlation with TPS and deactivates MAPK-mediated signalling [100].